These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6603085)

  • 1. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
    Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
    J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of ventricular tachycardia in infancy and childhood with amiodarone].
    Batisse A; Sardet A; Fermont L; Kachaner J
    Arch Mal Coeur Vaiss; 1982 Aug; 75(8):829-35. PubMed ID: 6814383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS
    Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
    Pickoff AS; Singh S; Flinn CJ; Wolff GS; Gelband H
    Dev Pharmacol Ther; 1983; 6(2):73-82. PubMed ID: 6861598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation.
    Heger JJ; Prystowsky EN; Jackman WM; Naccarelli GV; Warfel KA; Rinkenberger RL; Zipes DP
    N Engl J Med; 1981 Sep; 305(10):539-45. PubMed ID: 6789201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
    Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
    Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone: correlation of serum concentration with suppression of complex ventricular ectopic activity.
    Mostow ND; Rakita L; Vrobel TR; Noon DL; Blumer J
    Am J Cardiol; 1984 Sep; 54(6):569-74. PubMed ID: 6475775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
    Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
    Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
    Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone].
    Cassagneau B; Calazel J; Puel J; Massabuau P; Tournadre P; Fauvel JM; Bounhoure JP; Marin T; Narula OS
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):766-72. PubMed ID: 6433839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.